TABLE 1.
Timeline of post‐transplant treatment events.
Timeline | Events |
---|---|
Operative day | Kidney transplantation; living relative as the donor |
+9 days | US: 16 × 9 × 9 cm peri‐transplant fluid collection, lymphocele |
+21 days | Renal biopsy: No evidence of rejection. Absence of DSA |
+24 days | Laparoscopic peritoneal window |
+32 days | US: Small amount ascites. Normal transplant kidney |
+42 days |
Renal biopsy: Moderate epithelial foot process effacement. No evidence of rejection. Absence of DSA Treated with steroids |
+60 days | NM MAG3 scan: Negative for obstruction |
+72 days |
Renal biopsy: Intact epithelial foot process. No evidence of rejection VCUG: Normal Tacrolimus pharmacokinetic study: Normal |
+163 days |
Renal biopsy: ACR, Banff 1A. Negative C4d. Absence of DSA. Treated with ATG (1 mg/kg) and steroids |
+194 days |
Renal biopsy: Borderline for ACR. Tubular injury was characterized by isometric vacuoles and Tamm‐Horsfall (uromodulin) protein extravasation. Absence of DSA. dd‐cfDNA < 0.18% NM MAG3 scan: Prolonged cortical uptake in transplant kidney Cystogram and retrograde pyelogram: No evidence of obstruction Tacrolimus was switched to envarsus and everolimus, due to concern of CNI toxicity |
+235 days | Renal biopsy: Acute tubular injury, which might be secondary to hypoperfusion or nephrotoxic etiologies |
+285 days | COVID test: Positive. |
+311 days | Absence of DSA. dd‐cfDNA < 0.08% |
+339 days |
Renal biopsy: borderline ACR Treated with steroids |
+396 days | Conversion to Belatacept |
+408 days |
Urodynamic study: Normal VCUG: Normal |
+410 days | Right ankle swelling. Lower extremity duplex US was negative for superficial or deep vein thrombosis |
+444 days |
Renal biopsy: ACR, Banff 1A Treated with steroids |
+469 days | Influenza A infection |
+479 days |
Left leg swelling. Left popliteal, posterior tibial, peroneal and soleal vein thrombosis on Lower extremity duplex US Hypercoagulation panel: negative Treated with apixaban for 3 months |
+542 days |
Right inguinal hydrocele was diagnosed at outside hospital US: normal transplant kidney with patent vasculature |
+573 days |
Worsened proteinuria with development lower extremity edema despite normal albumin (4 g/dL) Treated with rituximab and IVIG infusion. Belatacept stopped. Converted to cyclosporine and mycophenolate mofetil |
+651 days |
Significant back pain with right groin and right leg swelling Outside doppler US: questionable lower extremity thrombosis and unremarkable allograft study CT venogram: extensive clot burden in the inferior iliac vein, bilateral iliac veins and transplant renal vein Thrombolysis with serial mechanical thrombectomy |
+711 days |
MRA: patent inferior vena cava, bilateral common iliac veins, bilateral external iliac veins, bilateral internal iliac veins and right transplant renal vein |
Abbreviations: ACR, acute cellular rejection; ATG, Anti‐thymocyte globulin; CNI, calcineurin inhibitor; CT, Computed tomography; dd‐cfDNA, donor‐derived cell‐free deoxyribonucleic acid; DSA, donor specific antibody; IVIG, intravenous immunoglobulin; MRA, Magnetic resonance angiography; NM MAG3 scan, Nuclear medicine renal flow and function mercaptoacetyltriglycine scan; US, ultrasound; VCUG, voiding cystourethrogram.